NEW YORK, NY--(Marketwire - August 19, 2011) - INC Research, LLC (the “Company”), a leading late stage contract research organization, will conduct a conference call to discuss its second quarter financial results at 11a.m ET on Wednesday, August 24, 2011. The second quarter financial results will also be available on the Company’s secure website at the opening of business on Monday, August 22, 2011.
To access the financial results and dial-in information for the conference call, a party must pre-register and certify that it is eligible to do so. Access to the financial results and conference call will be available only to (1) holders of the Company’s 11.5% Senior Notes due 2019, (2) securities analysts and (3) prospective investors that certify that they are qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended. To receive information on how to pre-register and certify eligibility, parties must send an email to wlumpkin@incresearch.com requesting access to the financial results and conference call information no later than August 23, 2011.
About INC Research, LLC
INC Research is a therapeutically focused contract research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women’s health trials. The company’s Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com.
Contacts
INC Research, LLC
Willis Lumpkin
Treasurer
919-341-3230
David Gill
CFO
919-745-2716
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
